Medical Imaging Conference Critical Path Opportunities List: From Opportunities to Action
|Event Date/Time: Oct 12, 2006||End Date/Time: Oct 13, 2006|
The workshop begins with a discussion of regulatory leaders on opportunities and perspectives for medical imaging in drug development. Representatives from industry and academia will then address imaging through the development continuum from Phase 0 through Phase IV.
In addition, specific opportunities for applying imaging in drug development will be addressed, focusing on the current state of qualification and what is needed to advance the modality as a biomarker or surrogate endpoint.
Industry, academic, and other imaging specialists will discuss the issues that widespread use of medical imaging faces from their perspectives, including imaging biomarkers in the development of treatments in cardiovascular disease, neuro-cognitive disorders, cancer, and arthritis.